Literature DB >> 10623646

The p53 tumor suppressor gene in ductal carcinoma in situ of the breast.

J F Simpson1, D L Page.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10623646      PMCID： PMC1868620          DOI： 10.1016/S0002-9440(10)64698-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  12 in total

1.  Ductal carcinoma in situ--the focus for prevention, screening, and breast conservation in breast cancer.

Authors:  D L Page; J F Simpson
Journal:  N Engl J Med       Date:  1999-05-13       Impact factor: 91.245

2.  Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone.

Authors:  W L Betsill; P P Rosen; P H Lieberman; G F Robbins
Journal:  JAMA       Date:  1978-05-05       Impact factor: 56.272

3.  Heterogeneity of intraductal carcinoma of the breast.

Authors:  A S Patchefsky; G F Schwartz; S D Finkelstein; A Prestipino; S E Sohn; J S Singer; S A Feig
Journal:  Cancer       Date:  1989-02-15       Impact factor: 6.860

4.  p53 mutations and expression in breast carcinoma in situ.

Authors:  J Lukas; N Niu; M F Press
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

5.  Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions.

Authors:  W J Lennington; R A Jensen; L W Dalton; D L Page
Journal:  Cancer       Date:  1994-01-01       Impact factor: 6.860

6.  p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.

Authors:  F P O'Malley; C L Vnencak-Jones; W D Dupont; F Parl; S Manning; D L Page
Journal:  Lab Invest       Date:  1994-07       Impact factor: 5.662

7.  Maintenance of p53 alterations throughout breast cancer progression.

Authors:  A M Davidoff; B J Kerns; J D Iglehart; J R Marks
Journal:  Cancer Res       Date:  1991-05-15       Impact factor: 12.701

8.  Incidence of and treatment for ductal carcinoma in situ of the breast.

Authors:  V L Ernster; J Barclay; K Kerlikowske; D Grady; C Henderson
Journal:  JAMA       Date:  1996-03-27       Impact factor: 56.272

9.  Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy.

Authors:  D L Page; W D Dupont; L W Rogers; R A Jensen; P A Schuyler
Journal:  Cancer       Date:  1995-10-01       Impact factor: 6.860

10.  p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade.

Authors:  H Tsuda; K Iwaya; T Fukutomi; S Hirohashi
Journal:  Jpn J Cancer Res       Date:  1993-04
View more
  2 in total

1.  Expression of secreted frizzled-related protein 2 in a primary canine mammary tumor cell line: a candidate tumor marker for mammary tumor cells.

Authors:  Jia-Lin Lee; Ching-Jin Chang; Ling-Ling Chueh; Chung-Tien Lin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 May-Jun       Impact factor: 2.416

Review 2.  A new model for ductal carcinoma in situ suggests strategies for treatment.

Authors:  William John Gullick
Journal:  Breast Cancer Res       Date:  2002-07-19       Impact factor: 6.466
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.